Indications and Purposes
| 1 Indications And Usage Zytiga Is Indicated In Combination With Prednisone For The Treatment Of Patients With Metastatic Castration-Resistant Prostate Cancer (crpc) Metastatic High-Risk Castration-Sensitive Prostate Cancer (cspc) Zytiga Is A Cyp17 Inhibitor Indicated In Combination With Prednisone For The Treatment Of Patients With Metastatic Castration-Resistant Prostate Cancer (crpc). ( 1 ) Metastatic High-Risk Castration-Sensitive Prostate Cancer (cspc). ( 1 ) |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Abiraterone Acetate |
|
ZINC5224164 |